Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flyvbjerg, A.
Right arrow Articles by Rasch, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flyvbjerg, A.
Right arrow Articles by Rasch, R.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:3090-3094, 2002
© 2002 by the American Diabetes Association, Inc.

Amelioration of Long-Term Renal Changes in Obese Type 2 Diabetic Mice by a Neutralizing Vascular Endothelial Growth Factor Antibody

Allan Flyvbjerg1, Frederik Dagnæs-Hansen2, An S. De Vriese3, Bieke F. Schrijvers1,3, Ronald G. Tilton4, and Ruth Rasch5

1 Medical Department M and Medical Research Laboratories, Institute of Experimental Clinical Research, Aarhus University Hospital, Aarhus, Denmark
2 Department of Medical Microbiology and Immunology, University of Aarhus, Aarhus, Denmark
3 Renal Unit, Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium
4 Department of Pharmacology, Texas Biotechnology Corporation, Houston, Texas
5 Department of Cell Biology, Institute of Anatomy, Aarhus University, Aarhus, Denmark

Diabetic nephropathy in type 2 diabetic patients is a frequent complication associated with increased morbidity and mortality. Various growth factors and cytokines have been implicated in the pathogenesis of diabetic kidney disease, including vascular endothelial growth factor (VEGF). To explore a role for VEGF in renal changes in type 2 diabetes, we examined the renal effects of a neutralizing murine VEGF antibody in the diabetic db/db mouse, a model of obese type 2 diabetes. One group of db/db mice was treated for 2 months with a VEGF antibody, while another db/db group was treated for the same period with an isotype-matched irrelevant IgG. A third group consisting of nondiabetic db/+ mice was treated with the same isotype-matched IgG for 2 months. Placebo-treated db/db mice showed a pronounced increase in kidney weight, glomerular volume, basement membrane thickness (BMT), total mesangial volume, urinary albumin excretion (UAE), and creatinine clearance (CrCl) when compared with nondiabetic controls. In VEGF antibody-treated db/db mice, increases in kidney weight, glomerular volume, BMT, and UAE were attenuated, whereas the increase in CrCl was abolished. VEGF antibody administration tended to reduce expansion in total mesangial volume. These effects in diabetic animals were seen without impact on body weight, blood glucose, insulin levels, or food consumption. In conclusion, chronic inhibition of VEGF in db/db mice ameliorates the diabetic renal changes seen in type 2 diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
C.-H. Ku, K. E. White, A. Dei Cas, A. Hayward, Z. Webster, R. Bilous, S. Marshall, G. Viberti, and L. Gnudi
Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice
Diabetes, October 1, 2008; 57(10): 2824 - 2833.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
F. Peng, D. Wu, B. Gao, A. J. Ingram, B. Zhang, K. Chorneyko, R. McKenzie, and J. C. Krepinsky
RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease
Diabetes, June 1, 2008; 57(6): 1683 - 1692.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Wang, F. N. Ziyadeh, E. Y. Lee, P. E. Pyagay, S. H. Sung, S. A. Sheardown, N. J. Laping, and S. Chen
Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1657 - F1665.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. Ostendorf, A. S. De Vriese, and J. Floege
Renal side effects of anti-VEGF therapy in man: a new test system
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2778 - 2780.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Boor, K. Sebekova, T. Ostendorf, and J. Floege
Treatment targets in renal fibrosis
Nephrol. Dial. Transplant., September 21, 2007; (2007) gfm393v1.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Advani, D. J. Kelly, S. L. Advani, A. J. Cox, K. Thai, Y. Zhang, K. E. White, R. M. Gow, S. M. Marshall, B. M. Steer, et al.
Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions
PNAS, September 4, 2007; 104(36): 14448 - 14453.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Meier, J. Menne, J.-K. Park, and H. Haller
Nailing down PKC isoform specificity in diabetic nephropathy two's company, three's a crowd
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2421 - 2425.
[Full Text] [PDF]

Home page
 IOVSHome page
E. J. Kuiper, J. M. Hughes, R. J. Van Geest, I. M. C. Vogels, R. Goldschmeding, C. J. F. Van Noorden, R. O. Schlingemann, and I. Klaassen
Effect of VEGF-A on Expression of Profibrotic Growth Factor and Extracellular Matrix Genes in the Retina
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4267 - 4276.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Krag, J. R. Nyengaard, and L. Wogensen
Combined effects of moderately elevated blood glucose and locally produced TGF-{beta}1 on glomerular morphology and renal collagen production
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2485 - 2496.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. J. Kelly, D. Buck, A. J. Cox, Y. Zhang, and R. E. Gilbert
Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F565 - F574.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. Feliers, M.-J. Lee, G. Ghosh-Choudhury, K. Bomsztyk, and B. S. Kasinath
Heterogeneous nuclear ribonucleoprotein K contributes to angiotensin II stimulation of vascular endothelial growth factor mRNA translation
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F607 - F615.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. Liu, M. Morimoto, S. Kitajima, T. Koike, Y. Yu, H. Shiiki, M. Nagata, T. Watanabe, and J. Fan
Increased Expression of Vascular Endothelial Growth Factor in Kidney Leads to Progressive Impairment of Glomerular Functions
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2094 - 2104.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. Menne, J.-K. Park, N. Shushakova, M. Mengel, M. Meier, and D. Fliser
The Continuous Erythropoietin Receptor Activator Affects Different Pathways of Diabetic Renal Injury
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2046 - 2053.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
T. Nakagawa
Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1665 - F1672.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
W. C. Aird
Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds
Circ. Res., February 2, 2007; 100(2): 174 - 190.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Meier, J.-K. Park, D. Overheu, T. Kirsch, C. Lindschau, F. Gueler, M. Leitges, J. Menne, and H. Haller
Deletion of Protein Kinase C-{beta} Isoform In Vivo Reduces Renal Hypertrophy but Not Albuminuria in the Streptozotocin-Induced Diabetic Mouse Model
Diabetes, February 1, 2007; 56(2): 346 - 354.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. T. Coughlan, V. Thallas-Bonke, J. Pete, D. M. Long, A. Gasser, D. C. K. Tong, M. Arnstein, S. R. Thorpe, M. E. Cooper, and J. M. Forbes
Combination Therapy with the Advanced Glycation End Product Cross-Link Breaker, Alagebrium, and Angiotensin Converting Enzyme Inhibitors in Diabetes: Synergy or Redundancy?
Endocrinology, February 1, 2007; 148(2): 886 - 895.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Nakagawa, W. Sato, O. Glushakova, M. Heinig, T. Clarke, M. Campbell-Thompson, Y. Yuzawa, M. A. Atkinson, R. J. Johnson, and B. Croker
Diabetic Endothelial Nitric Oxide Synthase Knockout Mice Develop Advanced Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 539 - 550.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M. P. Cohen, G. T. Lautenslager, E. Hud, E. Shea, A. Wang, S. Chen, and C. W. Shearman
Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F789 - F795.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
L. E. Burt, M. S. Forbes, B. A. Thornhill, S. C. Kiley, J. J. Minor, and R. L. Chevalier
Renal vascular endothelial growth factor in neonatal obstructive nephropathy. II. Exogenous VEGF
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F168 - F174.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
B. S. Kasinath, M. M. Mariappan, K. Sataranatarajan, M. J. Lee, and D. Feliers
mRNA Translation: Unexplored Territory in Renal Science
J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3281 - 3292.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. A. Long, W. Mu, K. L. Price, C. Roncal, G. F. Schreiner, A. S. Woolf, and R. J. Johnson
Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertension
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1248 - F1254.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
H. Xu, L. Zeng, H. Peng, S. Chen, J. Jones, T.-L. Chew, M. M. Sadeghi, Y. S. Kanwar, and F. R. Danesh
HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F995 - F1004.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. H. Sung, F. N. Ziyadeh, A. Wang, P. E. Pyagay, Y. S. Kanwar, and S. Chen
Blockade of Vascular Endothelial Growth Factor Signaling Ameliorates Diabetic Albuminuria in Mice
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3093 - 3104.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
P. Roestenberg, F. A. van Nieuwenhoven, J. A. Joles, C. Trischberger, P. P. Martens, N. Oliver, J. Aten, J. W. Hoppener, and R. Goldschmeding
Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice
Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1344 - F1354.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Ichinose, Y. Maeshima, Y. Yamamoto, M. Kinomura, K. Hirokoshi, H. Kitayama, Y. Takazawa, H. Sugiyama, Y. Yamasaki, N. Agata, et al.
2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice.
Diabetes, May 1, 2006; 55(5): 1232 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P. Katavetin, T. Miyata, R. Inagi, T. Tanaka, R. Sassa, J. R. Ingelfinger, T. Fujita, and M. Nangaku
High Glucose Blunts Vascular Endothelial Growth Factor Response to Hypoxia via the Oxidative Stress-Regulated Hypoxia-Inducible Factor/Hypoxia-Responsible Element Pathway
J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1405 - 1413.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
Y. S. Kang, Y. G. Park, B. K. Kim, S. Y. Han, Y. H. Jee, K. H. Han, M. H. Lee, H. K. Song, D. R. Cha, S. W. Kang, et al.
Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.
J. Mol. Endocrinol., April 1, 2006; 36(2): 377 - 388.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. Feliers, Y. Gorin, G. Ghosh-Choudhury, H. E. Abboud, and B. S. Kasinath
Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species
Am J Physiol Renal Physiol, April 1, 2006; 290(4): F927 - F936.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
E. Sugaru, T. Nakagawa, M. Ono-Kishino, J. Nagamine, T. Tokunaga, M. Kitoh, W. E. Hume, R. Nagata, and M. Taiji
SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice
Am J Physiol Renal Physiol, April 1, 2006; 290(4): F813 - F820.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Nakagawa, W. Sato, Y. Y. Sautin, O. Glushakova, B. Croker, M. A. Atkinson, C. C. Tisher, and R. J. Johnson
Uncoupling of Vascular Endothelial Growth Factor with Nitric Oxide as a Mechanism for Diabetic Vasculopathy
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 736 - 745.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
B. F. Schrijvers, A. Flyvbjerg, R. G. Tilton, N. H. Lameire, and A. S. De Vriese
A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat
Nephrol. Dial. Transplant., February 1, 2006; 21(2): 324 - 329.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. X. Zhang, J. J. Wang, K. Lu, R. Mott, R. Longeras, and J.-x. Ma
Therapeutic Potential of Angiostatin in Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 475 - 486.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. Zent and A. Pozzi
Antiangiogenic Therapy in Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 325 - 327.
[Full Text] [PDF]

Home page
 DiabetesHome page
K. Ichinose, Y. Maeshima, Y. Yamamoto, H. Kitayama, Y. Takazawa, K. Hirokoshi, H. Sugiyama, Y. Yamasaki, K. Eguchi, and H. Makino
Antiangiogenic Endostatin Peptide Ameliorates Renal Alterations in the Early Stage of a Type 1 Diabetic Nephropathy Model
Diabetes, October 1, 2005; 54(10): 2891 - 2903.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. M. Mariappan, D. Senthil, K. S. Natarajan, G. G. Choudhury, and B. S. Kasinath
Phospholipase C{gamma}-Erk Axis in Vascular Endothelial Growth Factor-induced Eukaryotic Initiation Factor 4E Phosphorylation and Protein Synthesis in Renal Epithelial Cells
J. Biol. Chem., August 5, 2005; 280(31): 28402 - 28411.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Z. Wang, T. Jiang, J. Li, G. Proctor, J. L. McManaman, S. Lucia, S. Chua, and M. Levi
Regulation of Renal Lipid Metabolism, Lipid Accumulation, and Glomerulosclerosis in FVBdb/db Mice With Type 2 Diabetes
Diabetes, August 1, 2005; 54(8): 2328 - 2335.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. Wolf, S. Chen, and F. N. Ziyadeh
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease: Podocyte Injury Comes of Age in Diabetic Nephropathy
Diabetes, June 1, 2005; 54(6): 1626 - 1634.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. Feliers, S. Duraisamy, J. L. Barnes, G. Ghosh-Choudhury, and B. S. Kasinath
Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II
Am J Physiol Renal Physiol, March 1, 2005; 288(3): F521 - F529.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
Endocr. Rev., December 1, 2004; 25(6): 971 - 1010.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Chen, Y. Kasama, J. S. Lee, B. Jim, M. Marin, and F. N. Ziyadeh
Podocyte-Derived Vascular Endothelial Growth Factor Mediates the Stimulation of {alpha}3(IV) Collagen Production by Transforming Growth Factor-{beta}1 in Mouse Podocytes
Diabetes, November 1, 2004; 53(11): 2939 - 2949.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
D. R. Cha, Y. S. Kang, S. Y. Han, Y. H. Jee, K. H. Han, J. Y. Han, Y. S. Kim, and N. H. Kim
Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats
J. Endocrinol., October 1, 2004; 183(1): 183 - 194.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
T. Nakagawa, H. Y. Lan, H. J. Zhu, D.-H. Kang, G. F. Schreiner, and R. J. Johnson
Differential regulation of VEGF by TGF-{beta} and hypoxia in rat proximal tubular cells
Am J Physiol Renal Physiol, October 1, 2004; 287(4): F658 - F664.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Menne, J.-K. Park, M. Boehne, M. Elger, C. Lindschau, T. Kirsch, M. Meier, F. Gueler, A. Fiebeler, F. H. Bahlmann, et al.
Diminished Loss of Proteoglycans and Lack of Albuminuria in Protein Kinase C-{alpha}--Deficient Diabetic Mice
Diabetes, August 1, 2004; 53(8): 2101 - 2109.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. Yamamoto, Y. Maeshima, H. Kitayama, S. Kitamura, Y. Takazawa, H. Sugiyama, Y. Yamasaki, and H. Makino
Tumstatin Peptide, an Inhibitor of Angiogenesis, Prevents Glomerular Hypertrophy in the Early Stage of Diabetic Nephropathy
Diabetes, July 1, 2004; 53(7): 1831 - 1840.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. Ray, M. Mishra, S. Ralph, I. Read, R. Davies, and P. Brenchley
Association of the VEGF Gene With Proliferative Diabetic Retinopathy But Not Proteinuria in Diabetes
Diabetes, March 1, 2004; 53(3): 861 - 864.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. C. Satchell, K. L. Anderson, and P. W. Mathieson
Angiopoietin 1 and Vascular Endothelial Growth Factor Modulate Human Glomerular Endothelial Cell Barrier Properties
J. Am. Soc. Nephrol., March 1, 2004; 15(3): 566 - 574.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Flyvbjerg, L. Denner, B. F. Schrijvers, R. G. Tilton, T. H. Mogensen, S. R. Paludan, and R. Rasch
Long-Term Renal Effects of a Neutralizing RAGE Antibody in Obese Type 2 Diabetic Mice
Diabetes, January 1, 2004; 53(1): 166 - 172.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Khamaisi, B. F. Schrijvers, A. S. De Vriese, I. Raz, and A. Flyvbjerg
The emerging role of VEGF in diabetic kidney disease
Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1427 - 1430.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Khamaisi, B. F. Schrijvers, A. S. De Vriese, I. Raz, and A. Flyvbjerg
The emerging role of VEGF in diabetic kidney disease
Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1427 - 1430.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.